Patents by Inventor Mengmeng DAI

Mengmeng DAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Facilitating communications with automated assistants in multiple languages
    Patent number: 11942082
    Abstract: Techniques described herein relate to facilitating end-to-end multilingual communications with automated assistants. In various implementations, speech recognition output may be generated based on voice input in a first language. A first language intent may be identified based on the speech recognition output and fulfilled in order to generate a first natural language output candidate in the first language. At least part of the speech recognition output may be translated to a second language to generate an at least partial translation, which may then be used to identify a second language intent that is fulfilled to generate a second natural language output candidate in the second language. Scores may be determined for the first and second natural language output candidates, and based on the scores, a natural language output may be selected for presentation.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: March 26, 2024
    Assignee: GOOGLE LLC
    Inventors: James Kuczmarski, Vibhor Jain, Amarnag Subramanya, Nimesh Ranjan, Melvin Jose Johnson Premkumar, Vladimir Vuskovic, Luna Dai, Daisuke Ikeda, Nihal Sandeep Balani, Jinna Lei, Mengmeng Niu, Hongjie Chai, Wangqing Yuan
  • Facilitating end-to-end communications with automated assistants in multiple languages
    Patent number: 11915692
    Abstract: Techniques described herein relate to facilitating end-to-end multilingual communications with automated assistants. In various implementations, speech recognition output may be generated based on voice input in a first language. A first language intent may be identified based on the speech recognition output and fulfilled in order to generate a first natural language output candidate in the first language. At least part of the speech recognition output may be translated to a second language to generate an at least partial translation, which may then be used to identify a second language intent that is fulfilled to generate a second natural language output candidate in the second language. Scores may be determined for the first and second natural language output candidates, and based on the scores, a natural language output may be selected for presentation.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: February 27, 2024
    Assignee: GOOGLE LLC
    Inventors: James Kuczmarski, Vibhor Jain, Amarnag Subramanya, Nimesh Ranjan, Melvin Jose Johnson Premkumar, Vladimir Vuskovic, Luna Dai, Daisuke Ikeda, Nihal Sandeep Balani, Jinna Lei, Mengmeng Niu
  • Platelet-derived growth factor B mutant, preparation method therefor and use thereof
    Patent number: 10450358
    Abstract: Provided are a platelet-derived growth factor B derivative, the encoding nucleic acid molecule thereof, and a vector and host cell having the nucleic acid molecule. Also provided are a preparation method for the mutant, and the use of the mutant in preparing medications for promoting cell division, cell proliferation, wound healing, skin regeneration, bone and tooth defect regeneration, and joint repair.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: October 22, 2019
    Assignee: Institute of Biotechnology Academy of Military Medical Sciences P.L.A. China
    Inventors: Wei Chen, Xiaopeng Zhang, Changming Yu, Ling Fu, Mengmeng Dai, Jun Zhang, Junjie Xu, Lihua Hou, Jianmin Li
  • Platelet-Derived Growth Factor B Mutant, Preparation Method Therefor and Use Thereof
    Publication number: 20170253642
    Abstract: Provided are a platelet-derived growth factor B derivative, the encoding nucleic acid molecule thereof, and a vector and host cell having the nucleic acid molecule. Also provided are a preparation method for the mutant, and the use of the mutant in preparing medications for promoting cell division, cell proliferation, wound healing, skin regeneration, bone and tooth defect regeneration, and joint repair.
    Type: Application
    Filed: July 16, 2015
    Publication date: September 7, 2017
    Applicant: Institute of Biotechnology Academy of Military Medical Sciences P.L.A. China
    Inventors: Wei CHEN, Xiaopeng ZHANG, Changming YU, Ling FU, Mengmeng DAI, Jun ZHANG, Junjie XU, Lihua HOU, Jianmin LI